Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved

Assunta Bianco; Paolo Maria Rossini; Massimiliano Mirabella

doi:10.1001/jamaneurol.2014.1135

Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved

Assunta Bianco
, Paolo Maria Rossini
, Massimiliano Mirabella

Risultato della ricerca: Contributo in rivista › Articolo

2 Citazioni (Scopus)

Abstract

Moving to fingolimod from natalizumab in multiple sclerosis-reply

Lingua originale	Inglese
pagine (da-a)	924-925
Numero di pagine	2
Rivista	JAMA Neurology
Volume	71
DOI	https://doi.org/10.1001/jamaneurol.2014.1135
Stato di pubblicazione	Pubblicato - 2014

Keywords

Antibodies, Monoclonal, Humanized
Drug Substitution
Female
Humans
Immunosuppressive Agents
Male
Multiple Sclerosis
Propylene Glycols
Sphingosine

Accesso al documento

10.1001/jamaneurol.2014.1135

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{b21d8ad1e136447fa4d39b4b9198c037,

title = "Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved",

abstract = "Moving to fingolimod from natalizumab in multiple sclerosis-reply",

keywords = "Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine, Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine",

author = "Assunta Bianco and Rossini, \{Paolo Maria\} and Massimiliano Mirabella",

year = "2014",

doi = "10.1001/jamaneurol.2014.1135",

language = "English",

volume = "71",

pages = "924--925",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved

AU - Bianco, Assunta

AU - Rossini, Paolo Maria

AU - Mirabella, Massimiliano

PY - 2014

Y1 - 2014

N2 - Moving to fingolimod from natalizumab in multiple sclerosis-reply

AB - Moving to fingolimod from natalizumab in multiple sclerosis-reply

KW - Antibodies, Monoclonal, Humanized

KW - Drug Substitution

KW - Female

KW - Humans

KW - Immunosuppressive Agents

KW - Male

KW - Multiple Sclerosis

KW - Propylene Glycols

KW - Sphingosine

KW - Antibodies, Monoclonal, Humanized

KW - Drug Substitution

KW - Female

KW - Humans

KW - Immunosuppressive Agents

KW - Male

KW - Multiple Sclerosis

KW - Propylene Glycols

KW - Sphingosine

UR - http://hdl.handle.net/10807/63929

U2 - 10.1001/jamaneurol.2014.1135

DO - 10.1001/jamaneurol.2014.1135

M3 - Article

SN - 2168-6149

VL - 71

SP - 924

EP - 925

JO - JAMA Neurology

JF - JAMA Neurology

ER -

Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo